Ionis Pharmaceuticals (NASDAQ: IONS) has experienced a notable increase in its stock price target, rising from $73.00 to $77.00 according to a report released by analysts...
On November 6, 2023, Wall Street Zen upgraded its rating for Structure Therapeutics (NASDAQ: GPCR) from “sell” to “hold.” This decision reflects a shift in sentiment...
On November 28, 2023, Wall Street Zen upgraded Structure Therapeutics (NASDAQ: GPCR) from a “sell” rating to a “hold” rating. This change comes as a part...
Equities researchers at Benchmark have initiated coverage of shares for Vital Farms (NASDAQ: VITL) with a “buy” rating and a price target of $60.00. This target...
Investment firm TD Cowen has initiated coverage of MACOM Technology Solutions (NASDAQ: MTSI) with a buy rating and a price target of $150.00, according to a...
TD Cowen has initiated coverage on shares of MACOM Technology Solutions (NASDAQ: MTSI), issuing a buy rating and a price target of $150.00. This announcement came...
Cytokinetics, Inc. (NASDAQ: CYTK) has received a price target increase from Citigroup, which raised its target from $77.00 to $84.00, as detailed in a research report...
